|
Thursday, January 19, 2023, San Francisco, California, 6:15 PM – 7:45 PM Pacific Time (9:15 PM – 10:45 PM Eastern Time)
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal CancersPart 2 of a 3-Part CME Symposium Series Held in Conjunction with the 2023 ASCO Gastrointestinal Cancers Symposium
Location
San Francisco Marriott Marquis 780 Mission Street San Francisco, CA 94103 Hotel Phone: (415) 896-1600 Program Schedule — Pacific Time 5:45 PM – 6:15 PM — Registration and Dinner 6:15 PM – 7:45 PM — Educational Meeting Meeting Room Golden Gate Ballroom — Salon A (B2 Level) This event will also be webcast live. Please see Registration tab for details. Faculty
Yelena Y Janjigian, MD Associate Professor Chief of Gastrointestinal Oncology Service Department of Medicine Memorial Sloan Kettering Cancer Center New York, New York Florian Lordick, MD, PhD Full Professor of Medicine at the University of Leipzig Director of the University Cancer Center Head of Department of Oncology Leipzig University Leipzig, Germany Zev Wainberg, MD, MSc Co-Director, GI Oncology Program Director of Early Phase Clinical Research Jonsson Comprehensive Cancer Center UCLA School of Medicine Los Angeles, California Moderator Samuel J Klempner, MD Associate Professor Massachusetts General Hospital Harvard Medical School Boston, Massachusetts This activity is supported by educational grants from Astellas, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo Inc, and Lilly.
Program Schedule — Pacific Time 5:45 PM – 6:15 PM — Registration and Dinner Buffet 6:15 PM – 7:45 PM — Educational Meeting MODULE 1: Optimizing the Selection of Therapy for Newly Diagnosed Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer — Dr Klempner
MODULE 2: Current Considerations in the Treatment of HER2-Positive Advanced Gastric/GEJ Adenocarcinoma — Dr Janjigian
MODULE 3: Selection and Sequencing of Therapy for Relapsed/Refractory Gastric/GEJ Cancer; Novel Investigational Approaches — Prof Lordick
MODULE 4: Current Approaches to the Management of Esophageal Cancer — Dr Wainberg
Target Audience
CME Credit Form FACULTY — The following faculty reported relevant financial relationships with ineligible entities: Dr Janjigian — Consulting Agreements: AmerisourceBergen, Arcus Biosciences, AstraZeneca Pharmaceuticals LP, Basilea Pharmaceutica Ltd, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Daiichi Sankyo Inc, Geneos Therapeutics, GSK, Imugene, Lilly, Lynx Health LLC, Merck, Merck Serono, Mersana Therapeutics Inc, Michael J Hennessy Associates Inc, Pfizer Inc, Rgenix, Seagen Inc, Silverback Therapeutics, Zymeworks Inc; Contracted Research: Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Genentech, a member of the Roche Group, Lilly, Merck, Rgenix; Nonrelevant Financial Relationship: Imedex, Paradigm Medical Communications, PeerView Institute. Prof Lordick — Consulting Agreements: Amgen Inc, Astellas, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Daiichi Sankyo Inc, Lilly, Merck Sharp & Dohme LLC, Novartis, Roche Laboratories Inc; Contracted Research: Bristol-Myers Squibb Company, Gilead Sciences Inc; Data and Safety Monitoring Board/Committee: BioNTech AG; Speakers Bureau: Amgen Inc, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo Inc, Incyte Corporation, Lilly, Merck Serono, Merck Sharp & Dohme LLC, Novartis, Roche Laboratories Inc, Servier Pharmaceuticals LLC; Nonrelevant Financial Relationship: Imedex, Medscape, MedUpdate, Streamedup. Dr Wainberg — Advisory Committee and Consulting Agreements: Arcus Biosciences, Astellas, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Daiichi Sankyo Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Lilly, Merck, Novartis, Pfizer Inc, Roche Laboratories Inc, Seagen Inc; Contracted Research: Arcus Biosciences, Bristol-Myers Squibb Company, Plexxikon Inc; Data and Safety Monitoring Board/Committee: Daiichi Sankyo Inc, Pfizer Inc.MODERATOR — Samuel J Klempner, MD – Advisory Committee: Astellas, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo Inc, Exact Sciences Corporation, Lilly, Merck, Mersana Therapeutics Inc, Novartis, Sanofi; Data and Safety Monitoring Board/Committee: Mersana Therapeutics Inc. Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersThis activity is supported by educational grants from Astellas, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo Inc, and Lilly. San Francisco Marriott Marquis
This activity is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers. IN-PERSON registration for clinicians in practice/healthcare professionals
Thank you for your interest in our CME program. At this time online preregistration is closed for this in-person event. SEATS ARE STILL AVAILABLE FOR THIS SESSION. Our onsite registration desk will be open at 5:45 PM PST on Thursday, January 19th. If you are interested in attending, please visit our registration desk located outside the Gold Gate Ballroom – Salon A (B2 Level) of the San Francisco Marriott Marquis hotel (780 Mission Street) within walking distance of the Moscone Convention Center (2 street blocks).
If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. NOTICE: Registration for this event is independent of registration for the 2023 ASCO GI Symposium. LIVE WEBCAST registration for all professionals
Please note we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. REGISTRATION FOR WEBCAST »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.
Not official events of the 2023 ASCO Gastrointestinal Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO®, CancerLinQ®, or Conquer Cancer®, the ASCO Foundation. |